InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,255.06
(
-1.79%
)
Post# of 426497
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ggwpq

Send PM Follow Ignore
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

ggwpq

Re: Whalatane post# 38147

Sunday, 11/09/2014 1:14:47 PM

Sunday, November 09, 2014 1:14:47 PM

Post# of 426497
Look at the potential combo opportunities

1) Atorvastatin-Vascepa
2) Lovastatin-Vascepa
3) Mevastatin-Vascepa
4) Pitavastatin-Vascepa
5) Rosuvastatin-Vascepa
6) Simvastatin-Vascepa

Most of the knowledgeable posters here know the synergistic effect of Vascepa & Statins on lipid bio-markers, with the Atorvastatin-Vascepa combo having the most pronounced effect (I hope Zum still has access to that Statin-Vascepa combo graph which I have trouble finding my copy). Amarin owns most if not all the combo patents. How much does any one of this combo patent worth? Not to mention Vascepa EU right which Amarin own one patent. It's not as bleak as what people think.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!